Scale-up/Technology Transfer

Breaking News | Facilities | Scale-up/Technology Transfer

West Pharmaceutical Services Opens New Office & Warehouse Facility in Seoul

Positions itself in key markets with enhanced scalability to support the future growth needs of its customers.

05.22.24

Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Galapagos, Blood Centers of America Enter Strategic CAR-T Mfg. Pact

Aims to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

05.16.24

Bio News | Breaking News | Scale-up/Technology Transfer

Veeva Systems Introduces Veeva Vault Basics

New offering is purpose-built to help biotechs scale for growth.

05.16.24

Formulation Development | Process Development | Scale-up/Technology Transfer

Three Key Considerations of Complex Liquid Formulations

In this white paper, we delve into three key factors that affect your product across its lifecycle.

05.13.24

Breaking News | cGMP Manufacture | Scale-up/Technology Transfer

Charles River Launches AAV and LVV Reference Materials Portfolio

Is designed to streamline Cell and Gene Therapy research and development as it scales to Good Manufacturing Practice quality.

05.02.24

Biologics, Proteins, Vaccines | Drug Development | Process Development | Scale-up/Technology Transfer

Prepared for the Next Pandemic - Utilizing New Production Capacities for Streamlined Vaccine Mfg

This informative webinar on May 28th will delve into the critical aspects of pandemic preparedness, focusing on vaccine development and production.

Sponsored released by IDT Biologika 05.01.24

Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer

Mosaic ImmunoEngineering to Acquire the Rights to Oncotelic’s Clinical-Stage Cancer Therapies

Will advance the development of Oncotelic’s necroptosis cancer therapy assets.

04.29.24

Breaking News | Clinical Trials | Collaborations & Alliances | Scale-up/Technology Transfer

FibroBiologics Discusses Opportunities to Work with Charles River

Anticipates a master services agreement for the development and manufacture of FibroBiologics’ fibroblast-based spheroid.

04.25.24

Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer

Vertex Obtains Exclusive License to TreeFrog’s C-Stem Technology

Aims to optimize production of its cell therapies for type 1 diabetes.

04.23.24

Breaking News | cGMP Manufacture | Collaborations & Alliances | Scale-up/Technology Transfer

BMS & Cellares Announce Worldwide Capacity Reservation & Supply Agreement

Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.

04.23.24

Breaking News | cGMP Manufacture | Collaborations & Alliances | Scale-up/Technology Transfer

Ferring and SK Pharmteco Partner to Increase Production of ADSTILADRIN

Will scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy.

04.18.24

Why Sofgen Pharmaceuticals?

Integrated services in development, scale up, commercial manufacturing and packaging.

04.04.24

Breaking News | Clinical Trial Materials | Collaborations & Alliances | Scale-up/Technology Transfer

Andelyn Biosciences Partners with Grace Science to Advance GS-100

Will tech transfer Phase I/II/III manufacturing of the suspension process adeno-associated virus (aav) gene therapy for NGLY1 deficiency.

03.25.24

Breaking News | Drug Development | Scale-up/Technology Transfer

Quantoom Biosciences Introduces New mRNA Kit

Ntensify mano is a cost-effective solution for mRNA production, combining convenience, efficiency, and control.

03.13.24

Breaking News | Methods Development | Scale-up/Technology Transfer

Rentschler Biopharma Contributes to 25% of FDA Approved Biopharmaceuticals in 2023

For the four newly approved products, Rentschler provided consulting, regulatory services, process development, technology transfer and manufacturing.

03.06.24

R&D | Scale-up/Technology Transfer

Novel Therapeutic Manufacturing Trends

This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.

03.04.24

APIs | Scale-up/Technology Transfer